Sigma-Aldrich Announces Agreement With IUBMB to Produce and Publish the Nicholson Metabolic Pathways Charts
Posted on: Thursday, 23 September 2004, 06:00 CDT
ST. LOUIS, Sept. 23 /PRNewswire-FirstCall/ -- Sigma-Aldrich Corporation is pleased to announce its collaboration with the International Union of Biochemistry and Molecular Biology (IUBMB) to produce and publish Metabolic Pathways Charts developed by esteemed scientist Donald Nicholson, D.Sc. The agreement grants Sigma-Aldrich the exclusive license to produce, distribute and sell the Nicholson Metabolic Pathways Charts in both printed and electronic form on a worldwide basis.
The Metabolic Pathways Charts were developed during a fifteen-year collaboration between Sigma-Aldrich and Dr. Nicholson. Sigma-Aldrich has enhanced this tool by placing it on its Enzyme Explorer web page and adding over 500 hyperlinks to its product listings ( http://sigma-aldrich.com/enzymeexplorer ). The Company and Dr. Nicholson are also in the process of animating several aspects of it.
Metabolic Pathways were created to provide a simple yet comprehensive schematic representation of how nutrients are utilized to produce energy and the naturally occurring biochemicals that are essential for the growth, mobility, reproduction and overall survival of all living things. Each of the Metabolic Pathways adds a valuable new resource to the toolbox used by researchers in the biological sciences. Since these pathways depict fundamental requirements for all life processes, classrooms as well as research laboratories will continue to utilize these charts.
Dr. Nicholson has been active in the life sciences for over 70 years. He received his B.Sc. in 1936 and his Ph.D in 1940, both in Chemistry from London University, and spent a distinguished career as a teacher of Bacteriology and Biochemistry at the Leeds School of Medicine.
He began developing the Metabolic Pathways Charts in 1955 "to make metabolism meaningful, wonder-full -- and fun" and they have now reached 22 editions. In 1997, he donated the copyright of all his work to the IUBMB. At 88 he is still actively engaged in the creation of smaller and more detailed "minimaps" and especially in the animation of some of the basic pathways. In recognition of his work he has received an Honorary D.Sc. and has been made one of only two Honorary Life Members of the IUBMB.
About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and chemical manufacturing. We have customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use our products. Sigma-Aldrich operates in 34 countries and has over 6,000 employees providing excellent service worldwide. We are committed to the success of our Customers, Employees and Shareholders through leadership in Life Science, High Technology and Service. For more information about Sigma- Aldrich, please visit our award-winning web site at http://sigma-aldrich.com/ .
About IUBMB: IUBMB is the International Union of Biochemistry and Molecular Biology. This worldwide umbrella organization comprises 66 adhering societies and eight associated organizations. IUBMB is member of The International Council of Science (ICSU). IUBMB fosters and supports the growth and advancement of biochemistry and molecular biology as the foundation from which the biomolecular sciences derive their basic ideas and techniques in the service of mankind.
This release contains forward-looking statements relating to future performance, goals, strategic actions and initiatives and similar intentions and beliefs and other statements regarding the Company's expectations, goals, beliefs, intentions and the like, which involve assumptions regarding Company operations and conditions in the markets the Company serves. The Company does not undertake any obligation to update these forward-looking statements.
Sigma-Aldrich Corporation
CONTACT: Kim Harper of Sigma-Aldrich Corporation, +1-314-286-8374
Web site: http://www.sigma-aldrich.com/http://sigma-aldrich.com/enzymeexplorer
Related Articles
- Sigma-Aldrich(R) Becomes First Life Science Company to Publish in PubMed's Peer-Reviewed Video Journal JoVE
- Sigma-Aldrich Announces Collaboration With Metahelix Life Sciences
- Sigma-Aldrich Enhances Internet-Based Bioactive Nutrient Explorer to Improve Customer Access to Nutrition Research Information
- Sigma-Aldrich Grants Pfizer Non-Exclusive Worldwide License to Use ddRNAi in Research Programs
- Sigma-Aldrich Introduces Stemline(TM) Neural Stem Cell Expansion Medium
- Sigma-Aldrich Welcomes the University of Edinburgh to the RNAi Partnership Program
- Sigma-Aldrich Expands Lentiviral shRNA Gene Family Sets
- Sigma-Aldrich Launches ChemBlogs: An Industry-First Web Tool for Open Scientific Discussion
- Sigma-Aldrich Expands Panorama(TM) Protein Array Product Line With Addition of Panorama(TM) Human Kinase V1 Array
- Sigma-Aldrich Launches GenElute(TM) HP Endotoxin-Free Kits
 |
 |
User Comments (0)
RSS Feeds